Shire considers new patent infringement suit from Watson on Adderall XR
28 February 2011
Nancy Faigen
Please Login to read the full article.
28 February 2011
Nancy Faigen
Nancy.faigen@informausa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Amgen resolves patent suit, squashing Teva's neutropenia biosimilar until 2013
- Teva and Alcobra to begin Phase III testing of non-stimulant ADHD drug in 2012
- US court rules Acorda's Zanaflex capsules patent invalid
- European generics firms, squeezed between innovators and payers, seek diversity
